|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1997-3-6
|
|
pubmed:abstractText |
To develop a therapeutic human high purity FVIII concentrate, treated with two documented and complementary specific inactivation methods, for the treatment of haemophilia A.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
spa
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0036-4355
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
41
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
125-30
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:9045352-Blood,
pubmed-meshheading:9045352-Blood Coagulation,
pubmed-meshheading:9045352-Blood Proteins,
pubmed-meshheading:9045352-Chemical Precipitation,
pubmed-meshheading:9045352-Chromatography, Affinity,
pubmed-meshheading:9045352-Cold Temperature,
pubmed-meshheading:9045352-Detergents,
pubmed-meshheading:9045352-Factor VIII,
pubmed-meshheading:9045352-Hemophilia A,
pubmed-meshheading:9045352-Heparin,
pubmed-meshheading:9045352-Hot Temperature,
pubmed-meshheading:9045352-Humans,
pubmed-meshheading:9045352-Phosphoric Acid Esters,
pubmed-meshheading:9045352-Polyethylene Glycols,
pubmed-meshheading:9045352-Polysorbates,
pubmed-meshheading:9045352-Solvents,
pubmed-meshheading:9045352-Viruses
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
[Development and characterization of a high-purity human factor VIII concentrate submitted to 2 specific virus inactivation treatments (FANDHI)].
|
|
pubmed:affiliation |
División de Investigación y Desarrollo, Instituto Grifols, Barcelona.
|
|
pubmed:publicationType |
Journal Article,
English Abstract
|
